The Generic Drugs Market is expected to be around US$ 883.5 Billion by 2028 at a CAGR of 8.7% in the given forecast period.
The market for the generic drug has been driven by new government activities to manufacture generic drugs and mainly to promote the use of generic drugs against deadly chronic diseases globally. The low cost of generic drugs is majorly responsible for thickening the growth of generic drugs market in new emerging markets of developing economies.
Generic drugs are artificially indistinguishable from their branded drug partners. Although generics are bioequivalent to the drugs that are branded, they are sold at a critical discount from branded drugs costs. According to the FDA endorsement, the Generic drugs ought to contain a similar dynamic fixing as their marked partner; it ought to be bioequivalent and should meet group necessities for character, quality, immaculateness, and quality. It ought to be indistinguishable on the course of administration and dose structure.
The global Generic Drugs market is segregated on the basis of Distribution Channel as Hospital Pharmacies and Retail Pharmacies. Based on Therapy Area the global Generic Drugs market is segmented in Respiratory, Genitourinary/Hormonal, Rheumatology, Diabetes, Oncology, Central nervous system (CNS), Cardiovascular, Dermatology, and Others. Based on Drug Delivery the global Generic Drugs market is segmented in Dermal/Topical, Inhalers, Oral, and Injectables.
The global Generic Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Generic Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Sun Pharmaceutical Industries Ltd., Aurbindo Pharma, Aspen Pharmacare, Fresenius Kabi Ag, Lupin, Endo Pharma, Teva Pharmaceuticals, Mylan NV, Sandoz (Novartis), Hospira (Pfizer Inc.), and others are among the major players in the global Generic Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Generic Drugs Market has been segmented as below:
Generic Drugs Market, By Distribution Channel
Generic Drugs Market, By Therapy Area
Generic Drugs Market, By Drug Delivery
Generic Drugs Market, By Region
Generic Drugs Market, By Company
The report covers:
Report Scope:
The global Generic Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Generic Drugs market share. Major industry players with significant revenue share include Sun Pharmaceutical Industries Ltd., Aurbindo Pharma, Aspen Pharmacare, Fresenius Kabi Ag, Lupin, Endo Pharma, Teva Pharmaceuticals, Mylan NV, Sandoz (Novartis), Hospira (Pfizer Inc.), and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Generic Drugs Market, By Distribution Channel
5.1 Introduction
5.2 Hospital Pharmacies
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Retail Pharmacies
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6. Generic Drugs Market, By Therapy Area
6.1 Introduction
6.2 Respiratory
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Genitourinary/Hormonal
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Rheumatology
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Diabetes
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Oncology
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Central nervous system (CNS)
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 Cardiovascular
6.8.1 Market Overview
6.8.2 Market Size and Forecast
6.9 Dermatology
6.9.1 Market Overview
6.9.2 Market Size and Forecast
6.10 Others
6.10.1 Market Overview
6.10.2 Market Size and Forecast
7. Generic Drugs Market, By Drug Delivery
7.1 Introduction
7.2 Dermal/Topical
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Inhalers
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Oral
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Injectables
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. Generic Drugs Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Generic Drugs, By Distribution Channel
8.2.2 North America Generic Drugs, By Therapy Area
8.2.3 North America Generic Drugs, By Drug Delivery
8.3 Europe
8.3.1 Europe Generic Drugs, By Distribution Channel
8.3.2 Europe Generic Drugs, By Therapy Area
8.3.3 Europe Generic Drugs, By Drug Delivery
8.4 Asia-Pacific
8.4.1 Asia-Pacific Generic Drugs, By Distribution Channel
8.4.2 Asia-Pacific Generic Drugs, By Therapy Area
8.4.3 Asia-Pacific Generic Drugs, By Drug Delivery
8.5 Rest of the World
8.5.1 Rest of the World Generic Drugs, By Distribution Channel
8.5.2 Rest of the World Generic Drugs, By Therapy Area
8.5.3 Rest of the World Generic Drugs, By Drug Delivery
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Sun Pharmaceutical Industries Ltd.
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Aurbindo Pharma
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Aspen Pharmacare
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Fresenius Kabi Ag
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Lupin
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Endo Pharma
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Teva Pharmaceuticals
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Mylan NV
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Sandoz (Novartis)
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Hospira (Pfizer Inc.)
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Generic Drugs Market has been segmented as below:
Generic Drugs Market, By Distribution Channel
Generic Drugs Market, By Therapy Area
Generic Drugs Market, By Drug Delivery
Generic Drugs Market, By Region
Generic Drugs Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
